dual IL 17 A & F nanobody typical response at 12 wks not significantly better - how many IL17 inhibs do we need?
Tweet Content
dual IL 17 A & F nanobody typical response at 12 wks not significantly better - how many IL17 inhibs do we need? @RheumNow #EULAR2024 https://t.co/50dIKyO0e4
Show on Archive Page
On
Display in Search Results
On
PDQ
Off